News
NARI
79.97
0.00%
0.00
BUZZ-Stryker rises after Citi resumes coverage with 'buy' rating
Reuters · 02/26/2025 17:33
Inari Medical Merges with Stryker, Delists from Nasdaq
TipRanks · 02/19/2025 14:18
Stryker completes acquisition of Inari Medical
TipRanks · 02/19/2025 13:35
Weekly Report: what happened at NARI last week (0210-0214)?
Weekly Report · 02/17/2025 09:23
Kadant To Replace Inari Medical In S&P SmallCap 600
NASDAQ · 02/14/2025 01:16
Kadant to replace Inari Medical in S&P 600 at open on 2/19
TipRanks · 02/13/2025 22:20
Kadant To Replace Inari Medical In S&P SmallCap 600 Effective Prior To The Opening Of Trading On February 19
Benzinga · 02/13/2025 22:17
More
Webull provides a variety of real-time NARI stock news. You can receive the latest news about Inari Medical, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About NARI
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.